Fevzi Altuntaş

9PUBLICATIONS
114CO-AUTHORS
Medical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCardiology (incl. cardiovascular diseases)Anaesthesiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 12, 2026
Evaluation of colonization with multidrug-resistant microorganisms and the incidence of attributable infections in patients undergoing hematopoietic stem cell transplantation.

Burcu Çalişkan Demirkiran, Gülşen Iskender, İpek Mumcuoğlu

|Apr 13, 2025
Anti-T lymphocyte globulin plus posttransplant cyclophosphamide 25 mg/kg versus posttransplant cyclophosphamide 50 mg/kg in patients with acute leukemias.

Abdullah Karakus, Tayfur Toptas, Mehmet Sinan Dal

|Nov 06, 2024
Survival Outcomes of Patients with Primary Plasma Cell Leukemia in the Era of Proteasome Inhibitors and Immunomodulatory Agents: A Real-Life Multicenter Analysis

Ünal Ataş, Ozan Salim, Utku Iltar

|Sep 13, 2024
A new scoring system to predict survival in elderly advanced stage Hodgkin lymphoma patients.

Özgür Mehtap, Tayfur Toptas, Mehmet S Dal

|May 30, 2024
COVID-19 in cancer patients: patient characteristics and outcomes in the post-COVID-19 vaccination period.

Gülşen Iskender, Duygu Mert, Göknur Yapar Toros

|Sep 13, 2021
Brentuximab vedotin and bendamustine: an effective salvage therapy for relapsed or refractory Hodgkin lymphoma patients.

Bahar Uncu Ulu, Mehmet Sinan Dal, İpek Yönal Hindilerden

Pageof 2

Frequent Collaborators

6 joint publications

Mehmet Sinan Dal

4 joint publications

Tuğçe Nur Yiğenoğlu

3 joint publications

Özgür Mehtap

3 joint publications

Turgay Ulaş